Cargando…
A Simple Methodology for Conversion of Mouse Monoclonal Antibody to Human-Mouse Chimeric Form
Passive immunotherapy has mainly been used as a therapy against cancer and inflammatory conditions. Recent studies have shown that monoclonal antibody-(mAb-) based passive immunotherapy is a promising approach to combat virus infection. Specific mouse mAbs can be routinely generated in large amounts...
Autores principales: | Dang, Vinh T., Mandakhalikar, Kedar D., Ng, Oi-Wing, Tan, Yee-Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775440/ https://www.ncbi.nlm.nih.gov/pubmed/24078817 http://dx.doi.org/10.1155/2013/716961 |
Ejemplares similares
-
Production, Binding and Cytotoxicity of Human/Mouse Chimeric Monoclonal Antibody‐Neocarzinostatin Conjugate
por: Yamaguchi, Toshiharu, et al.
Publicado: (1993) -
Establishment and Characterization of Mouse‐Human Chimeric Monoclonal Antibody to erbB‐2 Product
por: Ishida, Tadao, et al.
Publicado: (1994) -
A monoclonal antibody binds to threonine 49 in the non-structural 1 protein of influenza A virus and interferes with its ability to modulate viral replication
por: Barnwal, Bhaskar, et al.
Publicado: (2015) -
A Human/Mouse Chimeric Monoclonal Antibody against Intercellular Adhesion Molecule‐1 for Tumor Radioimmunoimaging
por: Yamamura, Miyuki, et al.
Publicado: (1996) -
Defucosylated mouse-dog chimeric anti-HER2 monoclonal antibody exerts antitumor activities in mouse xenograft models of canine tumors
por: Suzuki, Hiroyuki, et al.
Publicado: (2022)